Results 211 to 220 of about 20,887 (223)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

Oncogene, 2011
John Lunec, D A Tweddle, U R Kees
exaly  

Targeted expression of MYCN causes neuroblastoma in transgenic mice

EMBO Journal, 1997
Burt Feuerstein, William Weiss, Ken Aldape   +2 more
exaly  

Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma

European Journal of Cancer, 2007
Jan Koster, Íngrid Øra, Arjen Koppen   +2 more
exaly  

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors

Oncogene, 2009
Jo Vandesompele, Alexander Schramm, Pieter Mestdagh   +2 more
exaly  

Investigating the role of MYCN in alternate splicing in MYCN-amplified neuroblastoma

Neuroblastoma (NB) is one of the deadliest childhood tumours, responsible for 15% of childhood cancer mortality. Children classified as high-risk for disease relapse have a long-term survival of less than 50%. The treatment for high-risk NB is very aggressive and it is associated with severe toxicities.
openaire   +1 more source

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Pediatric Blood and Cancer, 2019
Katherine Matthay, Adela Canete, Garrett M Brodeur   +2 more
exaly  

Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?

Pediatric and Developmental Pathology
Alicia Andrews, Jefferson Terry
openaire   +2 more sources

Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells

Molecular Oncology, 2015
Dan Catchpoole, Y George Zheng, Zsombor Melegh   +2 more
exaly  

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

British Journal of Cancer, 2011
Christer Einvik
exaly  

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

European Journal of Cancer, 1997
M Kavallaris, G M Marshall, R G Deeley
exaly